BIO-key receives Nasdaq non-compliance notice for late 10-Q filing
BIO-key International received a notice from Nasdaq stating the company failed to timely file its Form 10-Q for the quarter ended March 31, 2026, violating Listing Rule 5250(c)(1). The Nasdaq Hearing Panel will determine whether the company maintains its listing on Nasdaq Capital
View filing at SEC.gov →